Skip to main content
Contact Us
Subscribe
E-Edition
69°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about RHHVF
Recent news which mentions RHHVF
< Previous
1
2
3
4
5
Next >
Roche Agrees To Purchase Part Of COVID-19 Test Player LumiraDx Diagnostics Platform For $295M
January 02, 2024
Tickers
LMDX
NEWS
RHHBF
RHHBY
Tags
RHHBF
RHHVF
Briefs
From
Benzinga
Poseida Therapeutics' New Treatment For Multiple Myeloma Shows Early Success In Clinical Trial
December 11, 2023
Tickers
PSTX
RHHBF
RHHBY
RHHVF
Tags
RHHVF
RHHBF
PSTX
From
Benzinga
Roche's Combination Therapy Shows Improved Progression Free Survival In Certain Breast Cancer With Mutation
December 05, 2023
Tickers
RHHBF
RHHBY
RHHVF
Tags
Biotech
Large Cap
Briefs
From
Benzinga
Roche Joins Bandwagon To Challenge Novo Nordisk, Eli Lilly For Weight Loss Drugs
December 04, 2023
Tickers
LLY
NVO
RHHBF
RHHBY
Tags
RHHBY
General
M&A
From
Benzinga
Sarepta/Roche's Closely Watched Duchenne Gene Therapy Faces More FDA Scrutiny - Stock Tanks
October 31, 2023
Tickers
RHHBF
RHHBY
RHHVF
SRPT
Tags
Movers
Briefs
why it's moving
From
Benzinga
Roche Reports Nine Months Sales Growth Despite Lower Sales From COVID-19 Products
October 19, 2023
Tickers
RHHBF
RHHBY
RHHVF
Tags
RHHBY
General
News
From
Benzinga
What's Going On Cancer Player Monte Rosa Therapeutics Stock Today?
October 17, 2023
Tickers
GLUE
RHHBF
RHHBY
RHHVF
Tags
Contracts
Large Cap
Biotech
From
Benzinga
Is There A Blood Test for Alzheimer's? Progress Underway, But Not Quite Ready
October 11, 2023
Tickers
BIIB
DGX
ESALY
LH
Tags
ESALY
News
Briefs
From
Benzinga
Ionis-Roche Join Forces To Compete In Neurodegenerative Disease Space, Analyst Sees Short-Term Challenges
September 27, 2023
Tickers
ALNY
AZN
IONS
NVS
Tags
RHHBF
RHHVF
Expert Ideas
From
Benzinga
Biden Administration Restarts Distribution Of Free At Home COVID-19 Tests, After Suspending For Year
September 21, 2023
Tickers
A
ABT
BDX
BRKR
Tags
LH
Benzinga
QGEN
From
Benzinga
Hypertension Impacts 1.2B People - Alnylam's Gene Silencing Drug Candidate Hits the Mark in Phase 2 Study, Offering Hope
September 07, 2023
Tickers
ALNY
IONS
RHHBF
RHHBY
Tags
RHHVF
RHHBF
Analyst Color
From
Benzinga
Roche's Approved Lung Cancer Drug Beats Chemo In Rare Type Of Lung Cancer
September 01, 2023
Tickers
RHHBF
RHHBY
RHHVF
Tags
Biotech
News
Briefs
From
Benzinga
Cancer Treatment In 7 Minutes: UK's Health Service To Rollout Roche's Tencentriq Injection Cutting Treatment Time
August 30, 2023
Tickers
RHHBF
RHHBY
RHHVF
Tags
Market News
Benzinga
Biotech
From
Benzinga
Who Are Other Players Gaining From Roche's Accidental Lung Cancer Data Update
August 23, 2023
Tickers
BGNE
GILD
ITOS
MRK
Tags
BGNE
RHHBF
RHHVF
From
Benzinga
Roche's Accidental Lung Cancer Trial Data Leak: Shows Encouraging Early Data From Combination Therapy Study
August 23, 2023
Tickers
RHHBF
RHHBY
RHHVF
Tags
Market News
RHHVF
RHHBF
From
Benzinga
Third Time Lucky: Exelixis' Cabozantinib Combo Therapy Aces Pivotal Study In Prostate Cancer Patients
August 21, 2023
Tickers
EXEL
IPSEF
IPSEY
RHHBF
Tags
EXEL
Expert Ideas
RHHVF
From
Benzinga
Johnson & Johnson, Other Pharma Makers Anticipate Reformulated Injectable Drugs May Exclude Price Negotiations
July 28, 2023
Tickers
BMY
HALO
JNJ
MRK
Tags
Benzinga
HALO
Market News
From
Benzinga
Novo Nordisk's Obesity Drug Saxenda Not Included In WHO's Essential Drug List
July 26, 2023
Tickers
MKGAF
MKKGY
NVO
REGN
Tags
Market News
Benzinga
MKGAF
From
Benzinga
Alnylam Inks Co-Development, Co-Commercialization Pact With Roche For Hypertension Therapy
July 24, 2023
Tickers
ALNY
RHHBF
RHHBY
RHHVF
Tags
News
Biotech
ALNY
From
Benzinga
Republican Presidential Candidate Vivek Ramaswamy Founded Roivant In Discussions With Roche For $7B Stomach Disease(s) Drug Deal
July 14, 2023
Tickers
PFE
RHHBF
RHHBY
RHHVF
Tags
Market News
Benzinga
PFE
From
Benzinga
Roche's Approved Multiple Sclerosis Drug: Subcutaneous Injection At Par With Intravenous Infusion
July 13, 2023
Tickers
HALO
RHHBF
RHHBY
RHHVF
Tags
HALO
RHHVF
Benzinga
From
Benzinga
Roche's Bispecific Antibody With Fixed-Duration Treatment Scores FDA Approval For Type Of Lymphoma
June 16, 2023
Tickers
RHHBF
RHHBY
RHHVF
Tags
RHHBF
Benzinga
RHHVF
From
Benzinga
New Data Show Roche's Self-Administered Blood Disorder Candidate Achieves Disease Control
June 09, 2023
Tickers
AZN
RHHBF
RHHBY
RHHVF
Tags
RHHVF
RHHBF
Benzinga
From
Benzinga
Roche's Investigational Drug For Relapsing Multiple Sclerosis Reduces Brain Lesions, Data Shows
May 17, 2023
Tickers
MKGAF
RHHBF
RHHBY
RHHVF
Tags
Briefs
News
SNY
From
Benzinga
Roche's Q1 Highlights: Increased Uptake Of Eye Disease Drug Cushions Sales Decline
April 26, 2023
Tickers
RHHBF
RHHBY
RHHVF
Tags
Large Cap
Biotech
News
From
Benzinga
FDA Approves Roche's Polivy Combo Therapy For Untreated Patients With Diffuse Large B-Cell Lymphoma
April 20, 2023
Tickers
RHHBF
RHHBY
RHHVF
Tags
Health Care
Large Cap
Biotech
From
Benzinga
EXCLUSIVE: FDA Grants Expedited Review Status To SAB Biotherapeutics' Influenza Antibody
April 13, 2023
Tickers
RHHBF
RHHBY
RHHVF
SABS
Tags
Health Care
Biotech
FDA Fast Track
From
Benzinga
New Four Year Data For Roche's Evrysdi Reinforces Long-Term Efficacy, Safety Profile In Muscular Atrophy Patients
March 20, 2023
Tickers
RHHBF
RHHBY
RHHVF
Tags
Health Care
Eurasia
Large Cap
From
Benzinga
FDA Casts Doubts Over Roche's Polivy Label Expansion For Untreated Lymphoma Setting
March 09, 2023
Tickers
RHHBF
RHHBY
RHHVF
Tags
Briefs
News
RHHBY
From
Benzinga
Roche, Exelixis Report Second Flop Out Of Three Trials Evaluating Cabozantinib/Atezolizumab Combo
March 03, 2023
Tickers
EXEL
RHHBF
RHHBY
RHHVF
Tags
EXEL
RHHBF
RHHVF
From
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.